ILC Research Publication Library

The Lobular Breast Cancer Alliance has compiled a reference list of ILC research and studies related to lobular breast cancer.  The list includes studies from 2000 to the present.  We will update this research list periodically.  Follow @LobularBCA and #lobular on Twitter to access up-to-date research.

How to use this table: Use the headers on the columns to sort by category.   Use the Search function to locate specific study topics.   To read a full article with restricted access consult a local medical library or purchase access to the full article (LBCA can not send or link to restricted articles due to license limitations). Suggestions for additions or changes to this list can be emailed to info@lobularbreastcancer.org for review.  Patients utilizing this publications library are encouraged to discuss all studies with their providers.  Updated June, 2020

Publications and Articles

NOTE:  Scroll left within the table for links to the full study or abstract.

Author
TITLEPUBLICATIONDATEType of ArticleGeneral SubjectSpecific SubjectLink
AbreuInvasive lobular carcinoma: a rare presentation in the male breastBMJ Case report2016Case ReportClinicopathologicalILC in Male patientshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885473/
AdachiComparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinomaBMC Cancer2016RetrospectiveClinicopathologicalPrognosishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807554/
AdachiComparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinomaBreast Cancer2018RetrospectiveSurgeryLymph node metastasishttps://www.ncbi.nlm.nih.gov/pubmed/29536376
AnCdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the BreastCell Reports2018Laboratory ResearchGenomicsLab Modelshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276789/
AnwarInvasive lobular carcinoma of the breast: Should this be regarded as a chronic disease?Intl J Surg2010RetrospectiveClinicopathologicalPrognosishttps://www.sciencedirect.com/science/article/pii/S1743919110000658
ArpinoInfiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcomeBreast Cancer Research2004RetrospectiveClinicopathologicalPrognosishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC400666/
ArthurMolecular Changes in Lobular Breast Cancers in Response to Endocrine TherapyCancer Res2014RetrospectiveGenomicsAnti-estrogen Therapyhttp://cancerres.aacrjournals.org/content/74/19/5371.long
BaePreoperative MR Imaging in Women with Breast Cancer Detected at Screening USRadiology2017RetrospectiveImagingMRIhttps://pubs.rsna.org/doi/10.1148/radiol.2016160706
BagliaAlcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 YearsHormones and Cancer2017RetrospectiveRisk FactorsAlcohol usehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779634/
BajramiE-cadherin/ROS1 inhibitor synthetic lethality in breast cancerCancer Disc2018Laboratory ResearchCancer BiologyE-cadherinhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296442/
Barroso-SousaDifferences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implicationsAdv Med Onc2016ReviewClinicopathologicalTherapy Response and Resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952020/
BergDiagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancerRadiology2004RetrospectiveImagingImaging Modalitieshttps://www.ncbi.nlm.nih.gov/pubmed/15486214
BergeronAn exceptional metaplastic lobular breast carcinoma diagnosed through exome sequencing.J Clin Path2020Case ReportGenomicsMetaplastic Carcinomahttps://www.ncbi.nlm.nih.gov/pubmed/31980561
BertozziPrevalence, risk factors, and prognosis of peritoneal metastasis from breast cancerSpringer Plus2015RetrospectiveMetastasisPeritoneal Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641144/
BrunerLoss of E-Cadherin-Dependent Cell–Cell Adhesion and the Development and Progression of CancerCSH Perspectives2018ReviewCancer BiologyE-cadherinhttps://cshperspectives.cshlp.org/content/10/3/a029330.long
BuchananIs Pleomorphic Lobular Carcinoma Really a Distinct Clinical Entity?J Surg Oncol2008RetrospectiveClinicopathologicalPleomorphic ILChttps://www.ncbi.nlm.nih.gov/pubmed/18668643
CaoFrequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinomaCancer Letter2019Laboratory ResearchCancer biologyGenomicshttps://www.ncbi.nlm.nih.gov/pubmed/31229512/
CarbogninTargeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model.Breast2020Laboratory ResearchGenomicsPrognosishttps://www.ncbi.nlm.nih.gov/pubmed/32028173
CarcoforoInfiltrating Lobular Carcinoma of the Breast Presenting as Gastrointestinal Obstruction: A Mini ReviewJournal of Cancer2012Case ReportMetastasisGI Metastasishttp://www.jcancer.org/v03p0328.htm
ChenInvasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinomaPLOS One2017RetrospectiveClinicopathologicalPrognosishttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182397
Chen21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancerBiomarkers in Medicine2018RetrospectiveGenomicsOncotype DX and Chemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/30565472
ChristgenLobular breast cancer: molecular basis, mouse and cellular modelsBreast Cancer Research2015ReviewCancer biologyLab Modelshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320436/
ChristgenLobular breast cancer: Clinical, molecular and morphological characteristicsPathology2016ReviewCancer biologyPathologyhttps://www.ncbi.nlm.nih.gov/pubmed/27233940
ChristgenOncogenic PIK3CA Mutations in Lobular Breast Cancer ProgressionGenes Chromosones Cancer2013RetrospectiveGenomicsPIK3CA Mutationshttps://www.ncbi.nlm.nih.gov/pubmed/22997091
ChristgenSubclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid‐papillary carcinomaJ Patho Clin Res2017Case ReportGenomicsPapillary Carcinomahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527319/
ChristofanilliInvasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival OutcomesJournal of Clinical Oncology2005RetrospectiveClinicopathologicalChemotherapyhttps://ascopubs.org/doi/full/10.1200/JCO.2005.03.111
CirielloComprehensive Molecular Portraits of Invasive Lobular Breast CancerCell2015Laboratory ResearchGenomicsGenetic basis of ILChttps://doi.org/10.1016/j.cell.2015.09.033
ConfortiEndocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrenceBreast Cancer Res2019RetrospectiveClinicopathologicalLate recurrence and metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937973/
ConlonIs There a Role for Oncotype Dx Testing in Invasive Lobular CarcinomaBreast Journal2015RetrospectiveGenomicsOncotype DXhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995885/
CoronaManagement of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancersBreast Cancer Res Treat2019RetrospectiveClinicopathologicalLymph node metastasishttps://www.ncbi.nlm.nih.gov/pubmed/32060782/
CorsoCDH1 germline mutations and hereditary lobular breast cancer.Fam Cancer2016ReviewHereditary breast cancerHereditary CDH1 mutationhttps://www.ncbi.nlm.nih.gov/pubmed/26759166
CostarelliPleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?Breast Cancer2017RetrospectiveCancer biologyPleomorphic ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726360/
CrownIntraoperative radiation therapy in early-stage breast cancer: Presence of lobularfeatures is not associated with increased rate of requiring additional therapy.Am J Surg2019RetrospectiveSurgeryIntra-operative Radiationhttps://www.ncbi.nlm.nih.gov/pubmed/31839176
Da RosHER2-positive lobular versus ductal carcinoma of the breast: pattern of first recurrence and molecular insights.Clin Breast Cancer2018RetrospectiveClinicopathologicalHer 2 Mutationhttps://pubmed.ncbi.nlm.nih.gov/29759595/
DabbsLobular versus ductal breast neoplasms: the diagnostic utility of p120 cateninAm J Surg Path2007RetrospectiveClinicopathologicalP120-Cateninhttps://www.ncbi.nlm.nih.gov/pubmed/17325485
DaniaAssociations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situBreast Cancer Res2019RetrospectiveRisk FactorsRace/ethinicity risk after LCIShttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854630/
DashevskyAppearance of untreated bone metastases from breast cancer on FDG PET/CT: Importance of histologic subtypeEur J Nucl Med Mol Imaging2015RetrospectiveImagingBone Metastaseshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558334/
de grootαE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancerJ Pathology2018Laboratory ResearchCancer BiologyE-cadherinhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055824/
de NonnevilleAdjuvant Chemotherapy in Lobular Carcinoma of the Breast: A Clinicopathological Score Identifies High-Risk Patient With Survival BenefitBreast Cancer Res2019RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/30759288
DelpechClinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomasBritish Journal of Cancer2013RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566807/
DeniziatERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomasOncotarget2016RetrospectiveGenomicsHER2 Mutationshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341983/
DerksenMammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in miceDis Model Mech2011Laboratory ResearchCancer BiologyLab models of ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097456/
DerksenSomatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesisCancer Cell2006Laboratory ResearchCancer BiologyLab models of ILC/Metastaseshttps://www.cell.com/cancer-cell/fulltext/S1535-6108(06)00288-1
DesmedtGenomic Characterization of Primary Invasive Lobular Breast CancerJ Clin Oncol2016Laboratory ResearchGenomicsGenetic basis of ILChttps://ascopubs.org/doi/abs/10.1200/JCO.2015.64.0334
DesmedtESR1 mutations in metastatic lobular breast cancer patientsnpj Breast Cancer2019RetrospectiveGenomicsESR1 Mutationhttps://www.nature.com/articles/s41523-019-0104-z
DesmedtImmune Infiltration in Invasive Lobular Breast CancerJ Natl Cancer Inst.2018RetrospectiveCancer biologyImmunologyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037125/
DessauvagieInvasive lobular carcinoma of the breast: assessment of proliferative activity using automated Ki-67 immunostainingPathology2019RetrospectiveClinicopathologicalKi67https://www.pathologyjournal.rcpa.edu.au/article/S0031-3025(19)30376-9/fulltext
DiPiroLobular breast cancer: patterns of intraabdominal metastatic spread on imaging and prognosticsignificance.Abdom Radiology2019RetrospectiveClinicopathologicalAbdominal Metastasishttps://www.ncbi.nlm.nih.gov/pubmed/30076430
DitchiLow risk of invasive lobular carcinoma of the breast in carriers of BRCA1 and TP53 (Li-Fraumeni syndrome) germline mutationsBreast Journal2018RetrospectiveHereditary breast cancerBRCA1/2 and p53 mutationhttps://onlinelibrary.wiley.com/doi/full/10.1111/tbj.13154
DixonInvasive lobular carcinoma: response to neoadjuvant letrozole therapyBreast Cancer Res Treat2011RetrospectiveClinicopathologicalAnti-estrogen Therapyhttps://www.ncbi.nlm.nih.gov/pubmed/21870129
DonaldsonBreast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsyCancer2018RetrospectiveRisk FactorsLCIS/Hyperplasiahttps://www.ncbi.nlm.nih.gov/pubmed/29023647
DossusLobular breast cancer: incidence and genetic and non-genetic risk factorsBreast Cancer Research2015ReviewGenomicsRisk and incidencehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357148/
DuKey regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancerBreast Cancer Research2018Laboratory ResearchCancer biologyAnti-estrogen resistancehttps://doi.org/10.1186/s13058-018-1041-8
EngstromInvasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypesHistopathology2015RetrospectiveClinicopathologicalPrognosishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329418/
FeltsAn Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.Breast j2017RetrospectiveGenomicsOncotype DXhttps://www.ncbi.nlm.nih.gov/pubmed/28097781
FranzoiLeptomeningeal carcinomatosis in patients with breast cancer.Crit Rev Oncol Hematol2019ReviewMetastasisLeptomeningal Metastasishttps://www.ncbi.nlm.nih.gov/pubmed/30819451
GainerInvasive Lobular Carcinoma Predicts Micrometastasis in Breast CancerJournal or Surgical Research2012Laboratory ResearchCancer biologyMetastasishttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419792/
GaoCDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancerLancet Oncol2019RetrospectiveClinicopathologicalCDK4/6 inhibitor responsehttps://www.ncbi.nlm.nih.gov/pubmed/31859246
GatzaAnother Breast Cancer Entity Confirmed: Genomics of Invasive Lobular Breast CancerJournal of Clinical Oncology2016ReviewGenomicsGenomics of ILChttp://ascopubs.org/doi/10.1200/JCO.2015.66.3872
GuiuInvasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?Crit Rev Onco Hematology2014ReviewClinicopathologicalTherapy Response and Resistancehttps://www.ncbi.nlm.nih.gov/pubmed/25129506/
GuvenSentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the BreastEuropean Journal Br Helath2018RetrospectiveMetastasisLymph node Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939975/
HaBreast MR Imaging before Surgery: Outcomes in Patients with Invasive Lobular Carcinoma by Using Propensity Score MatchingRadiology2018RetrospectiveImagingMRIhttps://pubs.rsna.org/doi/10.1148/radiol.2018171472
HansfordHereditary Diffuse Gastric Cancer Syndrome -CDH1 Mutations and BeyondJama Oncol2015RetrospectiveHereditary breast cancerHereditary CDH1 mutationhttps://jamanetwork.com/journals/jamaoncology/fullarticle/2108851
HarrellEstrogen induces c-Kit and an aggressive phenotype in a model of invasive lobular breast cancerOncogeniesis2107Laboratory ResearchCancer BiologyEstrogen signalinghttps://www.nature.com/articles/s41389-017-0002-x
HarrisonGenomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterationsMod Pathol2019RetrospectiveGenomicsHer2 mutation in Pleomorphic and Florid LCIShttps://www.ncbi.nlm.nih.gov/pubmed/31932682
HeDistant Metastatic Disease Manifestations in Infiltrating Lobular Carcinoma of the BreastAJR2014ReviewMetastasisMetastatic Siteshttps://www.ajronline.org/doi/full/10.2214/AJR.13.11156
HoganComparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal CarcinomaJ Nucl Med2015RetrospectiveImagingFDG PET/CThttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869690/
HornsveldRestraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancerCell Death Diff2016Laboratory ResearchCancer BiologyMetastasis /E-cadherinhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072425/
HoussamiMeta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancerBreast Canc Res Treat2017RetrospectiveImagingMRIhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580248/
HuAdjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0–1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER databaseBMC Cancer2020RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035707/
InoueSpecific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancerBreast Cancer2017RetrospectiveMetastasisMetastatic Siteshttps://www.ncbi.nlm.nih.gov/pubmed/28108967
IorfidaInvasive lobular breast cancer: subtypes and outcomeBreast Cancer Res Treat2012RetrospectiveClinicopathologicalPrognosishttps://www.ncbi.nlm.nih.gov/pubmed/22399188/
IshidaPleomorphic lobular carcinoma in a male breast: a case report with review of the literatureInt J Clin Exp Pathol2013Case ReportClinicopathologicalILC in Male patientshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693213/
JacobsIssues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the BreastThe Breast Journal2015ReviewClinicopathologicalTherapy Response and Resistancehttps://www.ncbi.nlm.nih.gov/pubmed/26782951
JohnsonLobular breast cancer series: imagingBreast Cancer Research2015ReviewImagingImaging Modalitieshttps://doi.org/10.1186/s13058-015-0605-0
KarjolBladder Metastasis from Breast Cancer: A Systematic ReviewCereus2020ReviewClinicopathologicalBladder Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117603/
KatzPrimary systemic chemotherapy of invasive lobular carcinoma of the breastLancet2007ReviewClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/17196511
KlarenbeekResponse of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune systemOncoimmunology2020Laboratory researchCancer BiologyTherapy Response (PI3K/mTOR)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028325/
KorhonenThe impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patientsThe Breast2013RetrospectiveClinicopathologicalMetastasishttps://www.thebreastonline.com/article/S0960-9776(13)00130-6/fulltext
KutasovicBreast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling studyJ Pathol Clin Res2019RetrospectiveGenomicsGynocological Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317061/
LaenkholmPopulation-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.Clin Breast Cancer2020RetrospectiveGenomicsBiomarkers of prognosis/PAM50https://www.ncbi.nlm.nih.gov/pubmed/32253134
LanglandsContralateral breast cancer: incidence according to ductal or lobular phenotype of the primaryClinical Radiology2016RetrospectiveClinicopathologicalContralateral Breast Cancerhttps://www.ncbi.nlm.nih.gov/pubmed/26703116
LevineFGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtypeNPJ Breast Cancer2019Laboratory ResearchGenomicsMetastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597581/
LiHormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.Cancer2000RetrospectiveRisk FactorsHormone Replacement Therapyhttps://www.ncbi.nlm.nih.gov/pubmed/10861435
LiChanging Incidence Rate of Invasive Lobular Breast Carcinoma among Older WomenCancer2000RetrospectiveRisk FactorsIncidencehttps://www.ncbi.nlm.nih.gov/pubmed/10861434
LiaoThe Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast CancerJ Cancer2018RetrospectiveClinicopathologicalTriple-negative ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771337/
LienFrequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast.Breast Canc Res Treat2017RetrospectiveGenomicsHER2 mutationhttps://www.ncbi.nlm.nih.gov/pubmed/25773929
LoganMolecular drivers of lobular carcinoma in situBreast Cancer Research2015ReviewCancer biologyLCIShttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453073/
LokadasanMetastatic lobular carcinoma of breast mimics primary cervix carcinoma: two case reports and a review of the literatureecancermedicalscience2015Case ReportMetastasisCervical Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583243/
LopezInvasive Lobular Carcinoma of the Breast: Spectrum of Mammo- graphic, US, and MR Imaging FindingsRadiographics2009ReviewImagingImaging modalitieshttps://pubs.rsna.org/doi/10.1148/rg.291085100
LuvetaInvasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic StrategyOncol and Therapy2019ReviewCancer BiologyGenomics and Treatmenthttps://link.springer.com/article/10.1007%2Fs40487-019-00105-0
MamtaniLobular Breast Cancer Different Disease, Different AlgorithmsSurgical Oncol Cinics2018ReviewClinicopathologicalGenomics of ILChttps://www.ncbi.nlm.nih.gov/pubmed/29132567
MamtaniLobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast CancerAnn Surg Oncol2019RetrospectiveSurgeryLymph Node Metastasishttps://www.ncbi.nlm.nih.gov/pubmed/31342363
MannMRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breastBreast Cancer Res Treat2008ReviewImagingMRIhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2096637/
MarmorRelative Effectiveness of Adjuvant Chemotherapy for Invasive Lobular Compared With Invasive Ductal Carcinoma of the BreastCancer2017RetrospectiveClinicopathologicalChemotherapyhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30699
MathewDistinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the BreastGeburtshilfe Frauenheilkd2017RetrospectiveMetastasisMetastatic siteshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489406/
MathieuThe poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profileEur J Cancer2004RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/14746851
McLemoreBreast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosisAnn Surg Onc2005RetrospectiveMetastasisGI Metastasishttps://www.ncbi.nlm.nih.gov/pubmed/16177864
Metzger-FilhoMagnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breastcarcinoma: results from the HERA trialJournal of Clinical Oncology2013RetrospectiveClinicopathologicalHER2-targeted therapyhttps://ascopubs.org/doi/10.1200/JCO.2012.46.2440
Metzger-FilhoRelative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 TrialJournal of Clinical Oncology2015RetrospectiveClinicopathologicalAnti-estrogen therapyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550691/
Metzger-FilhoGenomic grade adds prognostic value in invasive lobular carcinomaAnn Onc2013RetrospectiveGenomicsGene Signatureshttps://www.ncbi.nlm.nih.gov/pubmed/23028037
Metzger-FilhoMixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic GradeThe Oncologist2019RetrospectiveClinicopathologicalMixed ILC/IDChttp://theoncologist.alphamedpress.org/content/24/7/e441.long
MichautIntegration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancerSci Rep2016Laboratory ResearchGenomicsGenetic basis of ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700448/
MontagnaLobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and OutcomesClinical Breast Cancer2018RetrospectiveMetastasisMetastatic siteshttps://www.ncbi.nlm.nih.gov/pubmed/28778379/
MontanaghInvasive lobular carcinoma with papillary features: A newly described variant that poses a difficult histologic differential diagnosis.Breast J2020Case ReportClinicopathologalPapillary Carcinomahttps://www.ncbi.nlm.nih.gov/pubmed/32068324
MotenCharacterizing lobular carcinoma of the male breast using the SEER database.J surg Res2013RetrospectiveClinicopathologicalILC in Male patientshttps://www.ncbi.nlm.nih.gov/pubmed/24071024
MukhtarBreast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 PatientsAnnals of Surgical Oncol2018RetrospectiveSurgerySurgical methodshttps://www.ncbi.nlm.nih.gov/pubmed/30054826
MukhtarMitotic Score and Pleomorphic Histology in Invasive Lobular Carcinoma of the Breast: Impact on Disease-Free SurvivalBreast Cancer Res Treat2020RetrospectiveClinicopathologicalPleomorphic ILChttps://www.ncbi.nlm.nih.gov/pubmed/32240457
NagleLoss of E-cadherin Enhances IGF1–IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR InhibitorsClinical Cancer Research2018Laboratory ResearchCancer biologyCell signalinghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821389/
NarbeInvasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptorSpringer Plus2014RetrospectiveClinicopathologicalKi67https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925486/
OesterreichOpening the Door for Immune Oncology Studies in Invasive Lobular Breast CancerJ Natl Cancer Inst.2018CommentaryCancer biologyImmunologyhttps://academic.oup.com/jnci/article/110/7/696/4881762
OliveraEvolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methodsInsights Imaging2014ReviewImagingImaging modalitieshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999371/
OrvietoClinicopathologic characteristics of invasive lobular carcinoma of the breastCancer2008RetrospectiveClinicopathologicalPrognosishttps://onlinelibrary.wiley.com/doi/full/10.1002/cncr.23811
PatelValue Added of Preoperative Contrast-Enhanced Digital Mammography in Patients With Invasive Lobular Carcinoma of the BreastClinical Breast Cancer2018RetrospectiveImagingMammography methodshttps://www.ncbi.nlm.nih.gov/pubmed/30122347
Perez-GarciaEfficacy of Single-Agent Chemotherapy for Patients with Advanced Invasive LobularCarcinomaThe Oncologist2018RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/30578311
PestalozziDistinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International clinical trialsJ Clin Oncol2008RetrospectiveClinicopathologicalPrognosishttps://ascopubs.org/doi/full/10.1200/JCO.2007.14.9336
PetridisFrequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast CancerCancer Epidemiol Biomark2019RetrospectiveGenomicsGenetic basis of ILChttps://www.ncbi.nlm.nih.gov/pubmed/31263054/
PhalakSupplemental ultrasound screening in patients with a history of lobular neoplasiaThe Breast Journal2018RetrospectiveImagingLobular Neoplasiahttps://www.ncbi.nlm.nih.gov/pubmed/30675929
RaapHigh frequency of lobular breast cancer in distant metastases to the orbitCancer Med2015RetrospectiveMetastasisOribital Metastasishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312124/
RaapLobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.Lab Invest2017Laboratory ResearchCancer BiologyGenomics of ILChttps://www.nature.com/articles/labinvest2017106
RakhaInvasive lobular carcinoma of the breast: response to hormonal therapy and outcomesEur J Cancer2008RetrospectiveClinicopathologicalAnti-estrogen therapyhttps://www.ncbi.nlm.nih.gov/pubmed/18035533/
ReedInvasive lobular carcinoma of the breast: morphology, biomarkers and ’omicsBreast Cancer Research2015ReviewCancer biologyGenomics of ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310190/
ReedMixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphologyJ Pathology2018RetrospectiveCancer biologyMixed ductal-lobularhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873281/
ReedLobSig is a multigene predictor of outcome in invasive lobular carcinomaNPJ Breast Cancer2019Laboratory ResearchGenomicsGene signatureshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597578/
RigginsERRγ mediates Tamoxifen resistance in novel models of invasive lobular breast cancerCancer Res2008Laboratory ResearchCancer biologyAnti-estrogen resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701641/
Rosa-RosaHigh Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic FeaturesCancers2019RetrospectiveCancer biologyHER2 mutation in PLChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356653/
RossRelapsed Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene MutationsClinical Cancer Research2013RetrospectiveGenomicsHER2 mutation in ILChttp://clincancerres.aacrjournals.org/content/19/10/2668.long
SahinInvasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast CancerAm Surg2017RetrospectiveClinicopathologicalPleomorphic ILChttps://www.ncbi.nlm.nih.gov/pubmed/28424130
SawyerGenetic Predisposition to In Situ and Invasive Lobular Carcinoma of the BreastPLOS2014RetrospectiveGenomicsGenetic Basis of ILC/LCIShttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990493/
SchackmannCytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistanceJ Clin Invest2011Laboratory ResearchCancer BiologyP120-Cateninhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148719/
SchipperTruncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct MechanismsCancer Res2020Laboratory ResearchCancer BiologyLab Modelshttps://cancerres.aacrjournals.org/content/80/7/1486.long
SelinkoRole of sonography in diagnosing and staging invasive lobular carcinomaJ Clin Ultrasound2004RetrospectiveImagingImaging Methodshttps://www.ncbi.nlm.nih.gov/pubmed/15293298
SengerInvasive lobular carcinoma of the male breast – a systematic review with an illustrative case studyBreast Cancer2017Case ReportClinicopathologicalILC in male patientshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439541/
ShahPIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progressionBreast Cancer Research2017RetrospectiveGenomicsPIK3CA mutations in LCIShttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240238/
ShamirGenetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasivelobular carcinomaMod Pathol2020RetrospectiveGenomicsHer2 mutation in Pleomorphic and Florid LCIS/ILChttps://www.ncbi.nlm.nih.gov/pubmed/31907376
ShraderHereditary diffuse gastric cancer: association with lobular breast cancerFam Cancer2008Case ReportClinicopathologicalHerditary CDH1 mutationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2253650/
SikoraInvasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systemsSteroids2012ReviewCancer biologyAnti-estrogen therapyhttps://www.ncbi.nlm.nih.gov/pubmed/23178159
SikoraInvasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen responseCancer Resarch2014Laboratory ResearchCancer biologyAnti-estrogen response and resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955299/
SikoraWNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell linesBreast Cancer Research2016Laboratory ResearchCancer biologyAnti-estrogen response and resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028957/
SingletaryTreatment Trends in Early-Stage Invasive Lobular CarcinomaAnn Surgery2005RetrospectiveSurgerySurgical Methodshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1357735/
SledgeCollective Wisdom: Lobular Carcinoma of the BreastASCO2016ReviewCancer biologyTherapy response and resistancehttps://meetinglibrary.asco.org/record/154110/edbook
SokolLoss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancerAnn Oncol2018Laboratory ResearchGenomicsAnti-estrogen resistancehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336006/
StangeHigh-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of IBC cell linesClinical Cancer Research2006RetrospectiveGenomicsGenomics of ILChttp://clincancerres.aacrjournals.org/content/12/2/345.long
Strasser-WeipplOutcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestaneEuropean Journal of Cancer2018RetrospectiveClinicopathologicalAnti-estrogen therapyhttps://www.ncbi.nlm.nih.gov/pubmed/29274617
SwitzerCase series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tractCancer Treat Comm2015Case ReportMetastasisGI Metastasishttps://www.sciencedirect.com/science/article/pii/S2213089614000140
TalmanInvasive lobular breast cancer. Prognostic significance of histological malignancy gradingActa Onc2006RetrospectiveClinicopathologicalPrognosishttps://www.tandfonline.com/doi/full/10.1080/02841860601137397
TamarisaThe impact of chemotherapy sequence on survival in node-positive invasive lobular carcinomaJ Surg Onco2019RetrospectiveClinicopathologicalChemotherapyhttps://www.ncbi.nlm.nih.gov/pubmed/31062375/
TasdemirComprehensive phenotypic characterization of human invasive lobular carcinoma cell lines in 2D and 3D culturesCancer Resarch2018Laboratory ResearchCancer biologyLab modelshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507416/
Tenhagenp120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in MiceJ Mamm Gland Biol Neo2016Laboratory ResearchCancer BiologyP120 Cateninhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159444/
TeoE-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancerScientific Reports2018Laboratory ResearchCancer biologyCell signalinghttps://www.nature.com/articles/s41598-018-33525-5
ThomasInvasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage diseaseSemin Oncol2019ReviewClinicopathologicalNeoadjuvant Therapyhttps://www.ncbi.nlm.nih.gov/pubmed/31239068
ThorntonNeoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular CarcinomaAnn Surg Oncol2019RetrospectiveClinicopathologicalTherapy Responsehttps://www.ncbi.nlm.nih.gov/pubmed/31342392
TilleTumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinomaMod Pathol2020RetrospectiveCancer BiologyImmunologyhttps://pubmed.ncbi.nlm.nih.gov/32404955/
TruinDifferences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast CancerAnnals of Surgical Oncol2016RetrospectiveClinicopathologicalNeoadjuvent Chemotherapyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695495/
UlanerProspective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in IDC and ILCJournal of Nuclear Medicine2017ProspectiveImaging18 F-Fluciclovine PET/CThttp://jnm.snmjournals.org/content/58/7/1037.long
van de VenNuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through Kaiso-dependent Wnt11 expressionDis Model Mech2015Laboratory ResearchCancer BiologyP120 Cateninhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381336/
van de WaterInfluence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancerEur J Cancer2012RetrospectiveClinicopathologicalAnti-estrogen Therapyhttps://www.ejcancer.com/article/S0959-8049(12)00609-0/fulltext
van der PostHereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriersJ Med Genet2015ReviewRisk FactorsHereditary CDH1 Mutationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453626/
VargasPleomorphic lobular carcinoma of the breast: molecular pathology and clinical impactFuture Oncol2009ReviewGenomicsPleomorphichttps://www.ncbi.nlm.nih.gov/pubmed/19284381
Venema18F-FES PET Has Added Value in Staging and Therapy Decision Making in Patients With Disseminated Lobular Breast Cancer.Clin Nucl Med2017Laboratory ResearchImagingFES PEThttps://www.ncbi.nlm.nih.gov/pubmed/28604479/
VlugNuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancerCell Oncol2013Laboratory ResearchCancer BiologyCell Signalinghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777165/
WalshBET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer.Clin Can Res2019Laboratory ResearchCancer BiologyNovel therapeuticshttps://www.ncbi.nlm.nih.gov/pubmed/31409615
WangThe Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic SubtypesFrontiers in Genetics2018RetrospectiveGenomicsOncotype DXhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304349/
WilliamsDifferences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomasCancer Causes2019RetrospectiveClinicopathologalRacial Differences in ILC vs IDChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396692/
WinstonMetastatic Lobular Carcinoma of the Breast: Patterns of Spread in the Chest, Abdomen, and Pelvis on CTAJR2000RetrospectiveMetastasisMetastatic siteshttps://www.ajronline.org/doi/full/10.2214/ajr.175.3.1750795
WongEvaluating the Impact of Breast Density on Preoperative MRI in Invasive Lobular CarcinomaJ Am Coll Surg2018RetrospectiveImagingMRIhttps://www.ncbi.nlm.nih.gov/pubmed/29421692
XiaoMixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor statusScientific reports2017RetrospectiveClinicopathologicalMixed IDC/ILChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583173/
XicolaClinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteriaJ Med Genet2019RetrospectiveClinicopathologicalGenetic basis of ILChttps://jmg.bmj.com/content/56/12/838.long
XinA review of invasive lobular carcinoma of the breast: Should it be treated like invasive ductal carcinoma?Integr Cancer Sci Therapy2007ReviewClinicopathologicalPrognosishttps://www.oatext.com/pdf/ICST-3-211.pdf
YuClassical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristicsAm J Clinical Path2011Case ReportCancer biologyHER2 in ILChttps://academic.oup.com/ajcp/article/136/1/88/1766431